Bailin G, Huang J R
Department of Biochemistry, University of Medicine and Dentistry of New Jersey, School of Osteopathic Medicine, Piscataway 08854-5635.
Biochim Biophys Acta. 1989 Apr 6;995(2):122-32. doi: 10.1016/0167-4838(89)90070-8.
The (Ca2+ + Mg2+)-ATPase (ATP phosphohydrolase (Ca2+-transporting), EC 3.6.1.38) protein of rabbit skeletal sarcoplasmic reticulum (SR) rapidly incorporated 2 mol of 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) per 10(5) g of protein with little change in the Ca2+-dependent ATPase activity. When 2 additional mol of the reagent were bound the Ca2+-ATPase, activity was inhibited. The same pattern was found for modified intact SR and the Ca2+ uptake ability was inhibited. MgATP, CaATP and MgADP protected the Ca2+-ATPase activity concurrent with a decrease of about 1 mol of the NBD group per 10(5) g protein, but the Ca2+ uptake ability was not protected. Calcium alone had no effect on the modification. The modified ATPase protein or SR formed non-serial oligomers or aggregates, but the ATPase protein remained the predominant species present. In the presence of MgATP, oligomer formation was reduced partially but the major changes in the Ca2+-ATPase activity were due to the modification of the ATPase monomer. Thiolysis of the NBD-ATPase protein with dithiothreitol did not restore the Ca2+-ATPase activity, although more than 1 mol of the NBD group was removed from cysteine residues. Cysteine residues were modified in the NBD-ATPase protein or SR when the enzyme activity was inhibited. Trypsin digestion of NBD-SR or its ATPase protein released the A, B, A1, and A2 fragments. The A fragment and its subfragment A2 contained most of the label. Substrate MgATP protection studies showed that the A1 and A2 fragments were involved in maintaining the Ca2+-ATPase activity. Reagent-induced conformational changes of these fragments rather than direct active site group labeling accounted for the loss of ATPase activity.
兔骨骼肌肌浆网(SR)的(Ca2+ + Mg2+)-ATP酶(ATP磷酸水解酶(Ca2+转运),EC 3.6.1.38)蛋白每105 g蛋白能快速掺入2 mol的7-氯-4-硝基苯并-2-恶唑-1,3-二氮杂茂(NBD-Cl),而Ca2+依赖性ATP酶活性变化不大。当再结合2 mol该试剂时,Ca2+-ATP酶活性受到抑制。完整的经修饰SR也呈现相同模式,其Ca2+摄取能力受到抑制。MgATP、CaATP和MgADP可保护Ca2+-ATP酶活性,同时每105 g蛋白约减少1 mol的NBD基团,但Ca2+摄取能力未得到保护。单独的Ca2+对修饰无影响。修饰后的ATP酶蛋白或SR形成非连续的寡聚体或聚集体,但ATP酶蛋白仍是主要存在的种类。在MgATP存在下,寡聚体形成部分减少,但Ca2+-ATP酶活性的主要变化是由于ATP酶单体的修饰。用二硫苏糖醇对NBD-ATP酶蛋白进行巯基裂解,尽管从半胱氨酸残基上除去了超过1 mol的NBD基团,但Ca2+-ATP酶活性并未恢复。当酶活性受到抑制时,NBD-ATP酶蛋白或SR中的半胱氨酸残基被修饰。用胰蛋白酶消化NBD-SR或其ATP酶蛋白可释放出A、B、A1和A2片段。A片段及其亚片段A2含有大部分标记物。底物MgATP保护研究表明,A1和A2片段参与维持Ca2+-ATP酶活性。试剂诱导的这些片段的构象变化而非直接的活性位点基团标记导致了ATP酶活性的丧失。